What Are Induced Pluripotent Stem Cells?
Induced pluripotent stem cells (iPSCs) are adult cells reprogrammed into a youthful, embryo-like regenerative state.
This breakthrough changed regenerative medicine forever.
Instead of using embryonic tissue, doctors and scientists can potentially use adult cells and return them to pluripotency.
That is why many consider iPSCs the most exciting evolution beyond embryonic stem cell therapy.
Why This Matters
iPSCs may offer:
- Ethical advantages
- Personalized compatibility
- Tissue regeneration potential
- Anti-aging research potential
- Future custom therapies
Similar to Embryonic Stem Cells
They behave similarly because they can potentially become:
- Neurons
- Cardiac cells
- Skin cells
- Liver cells
- Pancreatic cells
This is why iPSCs are often called embryonic-like stem cells created from adult cells.
Current Interest Areas
Research is expanding in:
- Parkinson’s disease
- Vision restoration
- Diabetes
- Heart disease
- Orthopedic repair
- Age reversal science
Questions About iPSC Therapy?
Contact us for updated information on regenerative medicine programs and modern cellular therapies in Europe.
Information Notice:
The information on this page is intended for scientific, educational, and general informational purposes. Clinical approaches, availability, and regulatory status may vary by country, institution, and medical indication. For individual medical decisions, readers should consult qualified healthcare professionals and accredited medical centers.
The information on this page is intended for scientific, educational, and general informational purposes. Clinical approaches, availability, and regulatory status may vary by country, institution, and medical indication. For individual medical decisions, readers should consult qualified healthcare professionals and accredited medical centers.
Editorial Note:
This article has been prepared by the NBScience editorial team within the scope of clinical research, biotechnology, and international medical information.
This article has been prepared by the NBScience editorial team within the scope of clinical research, biotechnology, and international medical information.
